On August 26, 1998, the Attorneys General of Arizona, California, New Jersey, and Texas announced a multi-state settlement with Morinda, Inc., a multilevel company headquartered in Linden, Utah. The states had charged that Morinda had made unsubstantiated claims in consumer testimonials and other promotional material that its “Tahitian Noni” juice could treat, cure or prevent numerous diseases, including diabetes, depression, hemorrhoids and arthritis. Such claims rendered the beverage an unapproved new drug under state and federal food and drug laws and should not have been sold until it received approval. Under the terms of the agreement, Morinda must:
- No longer make drug claims, or claims that the product can cure, treat, or prevent any disease until “Tahitian Noni” is approved and cleared for those uses by the U.S. Food and Drug Adminstration.
- Not make any other claims, whether health claims or others, regarding the benefits of “Tahitian Noni” unless such claims are true and the company can substantiate the claim by reliable scientific evidence.
- Not use testimonials which imply that the advertised claimed results are the typical or ordinary experience of consumers in actual conditions of use, unless Morinda possesses and relies upon adequate substantiation that the results are typical or ordinary.
In addition, Morinda must refund to any consumer who requests a refund in writing, the full purchase price paid for the product. The agreement also calls for Morinda to pay $100,000 for investigative costs.
Regulatory Action in Finland
Press Release: November 23/30, 1998
For Aditional Information
- FDA warning letter to Bedessee Sporting Goods (9/15/00)
- FDA warning letter to Web Dreams Design (10/26/00)
- FDA warning letter to NPS Performance Marketing (5/6/02)
- FDA warning letter to Lifestyles Nutrition (5/6/02)
- FDA warning letter to Noni Juice Sales (5/6/02)
- FDA warning letter to Hawaiian Island Noni (7/31/02)
This page was revised on September 12, 2002.